nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphemanil Methylsulfate—CHRM3—epilepsy syndrome	0.315	0.518	CbGaD
Diphemanil Methylsulfate—CHRM1—epilepsy syndrome	0.294	0.483	CbGaD
Diphemanil Methylsulfate—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.141	0.431	CrCrCtD
Diphemanil Methylsulfate—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.097	0.296	CrCrCtD
Diphemanil Methylsulfate—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0895	0.273	CrCrCtD
Diphemanil Methylsulfate—Clidinium—CHRM3—epilepsy syndrome	0.000656	0.176	CrCbGaD
Diphemanil Methylsulfate—Clidinium—CHRM1—epilepsy syndrome	0.000612	0.164	CrCbGaD
Diphemanil Methylsulfate—Mepenzolate—CHRM3—epilepsy syndrome	0.000528	0.142	CrCbGaD
Diphemanil Methylsulfate—Mepenzolate—CHRM1—epilepsy syndrome	0.000492	0.132	CrCbGaD
Diphemanil Methylsulfate—Mepenzolate—CHRM2—epilepsy syndrome	0.000402	0.108	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—SLCO1A2—epilepsy syndrome	0.000401	0.108	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—ABCC2—epilepsy syndrome	0.000138	0.037	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—ABCG2—epilepsy syndrome	0.000122	0.0327	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—CYP2C19—epilepsy syndrome	9.58e-05	0.0257	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—PTGS2—epilepsy syndrome	8.31e-05	0.0223	CrCbGaD
Diphemanil Methylsulfate—Ketoprofen—ALB—epilepsy syndrome	7.4e-05	0.0199	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—CYP2D6—epilepsy syndrome	7.1e-05	0.0191	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—ABCB1—epilepsy syndrome	5.07e-05	0.0136	CrCbGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR9—epilepsy syndrome	2.28e-05	0.00038	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NPY2R—epilepsy syndrome	2.28e-05	0.00038	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR8—epilepsy syndrome	2.28e-05	0.00038	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADRA2A—epilepsy syndrome	2.28e-05	0.00038	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRM3—epilepsy syndrome	2.25e-05	0.000374	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRM4—epilepsy syndrome	2.25e-05	0.000374	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRM3—epilepsy syndrome	2.24e-05	0.000373	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRM4—epilepsy syndrome	2.24e-05	0.000373	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DUSP4—epilepsy syndrome	2.2e-05	0.000367	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SSTR2—epilepsy syndrome	2.2e-05	0.000367	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	2.2e-05	0.000367	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CXCL12—epilepsy syndrome	2.2e-05	0.000367	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DUSP4—epilepsy syndrome	2.2e-05	0.000366	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SSTR2—epilepsy syndrome	2.2e-05	0.000366	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CXCL12—epilepsy syndrome	2.19e-05	0.000365	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—BDKRB2—epilepsy syndrome	2.19e-05	0.000365	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CNR1—epilepsy syndrome	2.16e-05	0.00036	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—KCNJ11—epilepsy syndrome	2.16e-05	0.00036	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CNR1—epilepsy syndrome	2.15e-05	0.000359	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PLCB1—epilepsy syndrome	2.15e-05	0.000358	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PLCB1—epilepsy syndrome	2.14e-05	0.000357	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRM8—epilepsy syndrome	2.13e-05	0.000355	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PGF—epilepsy syndrome	2.13e-05	0.000355	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCR2—epilepsy syndrome	2.12e-05	0.000354	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—SST—epilepsy syndrome	2.12e-05	0.000354	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRM8—epilepsy syndrome	2.12e-05	0.000354	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PGF—epilepsy syndrome	2.12e-05	0.000354	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—SST—epilepsy syndrome	2.12e-05	0.000353	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCR2—epilepsy syndrome	2.12e-05	0.000353	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.11e-05	0.000351	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR7—epilepsy syndrome	2.1e-05	0.00035	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—POMC—epilepsy syndrome	2.08e-05	0.000347	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.08e-05	0.000346	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—POMC—epilepsy syndrome	2.08e-05	0.000346	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.07e-05	0.000345	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—CCL2—epilepsy syndrome	2.04e-05	0.00034	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—CCL2—epilepsy syndrome	2.03e-05	0.000339	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GNAO1—epilepsy syndrome	2.03e-05	0.000338	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—OPRD1—epilepsy syndrome	2.03e-05	0.000338	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GNAO1—epilepsy syndrome	2.02e-05	0.000337	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—OPRD1—epilepsy syndrome	2.02e-05	0.000337	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.01e-05	0.000334	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AKT3—epilepsy syndrome	2e-05	0.000333	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	2e-05	0.000333	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2e-05	0.000333	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CXCL12—epilepsy syndrome	1.99e-05	0.000332	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.99e-05	0.000332	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CNR1—epilepsy syndrome	1.96e-05	0.000327	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CNR1—epilepsy syndrome	1.95e-05	0.000326	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.95e-05	0.000326	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRM1—epilepsy syndrome	1.95e-05	0.000325	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PDYN—epilepsy syndrome	1.95e-05	0.000325	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCR7—epilepsy syndrome	1.95e-05	0.000325	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PLCB1—epilepsy syndrome	1.95e-05	0.000324	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRM1—epilepsy syndrome	1.94e-05	0.000323	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CHRM1—epilepsy syndrome	1.94e-05	0.000323	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PDYN—epilepsy syndrome	1.94e-05	0.000323	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR7—epilepsy syndrome	1.94e-05	0.000323	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR7—epilepsy syndrome	1.91e-05	0.000319	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR7—epilepsy syndrome	1.91e-05	0.000318	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.86e-05	0.000309	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HBEGF—epilepsy syndrome	1.85e-05	0.000308	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.83e-05	0.000305	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GAL—epilepsy syndrome	1.83e-05	0.000305	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GFAP—epilepsy syndrome	1.83e-05	0.000305	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CDC42—epilepsy syndrome	1.83e-05	0.000304	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GFAP—epilepsy syndrome	1.82e-05	0.000304	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GAL—epilepsy syndrome	1.82e-05	0.000304	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AKT3—epilepsy syndrome	1.82e-05	0.000304	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AKT3—epilepsy syndrome	1.82e-05	0.000303	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CHRM3—epilepsy syndrome	1.81e-05	0.000302	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRM5—epilepsy syndrome	1.81e-05	0.000302	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CASP2—epilepsy syndrome	1.81e-05	0.000302	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CASP2—epilepsy syndrome	1.8e-05	0.000301	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRM5—epilepsy syndrome	1.8e-05	0.000301	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AVP—epilepsy syndrome	1.77e-05	0.000295	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AVP—epilepsy syndrome	1.77e-05	0.000294	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ABCG2—epilepsy syndrome	1.76e-05	0.000293	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.74e-05	0.000289	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.73e-05	0.000288	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	1.71e-05	0.000286	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	1.7e-05	0.000284	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.7e-05	0.000284	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.7e-05	0.000284	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.7e-05	0.000284	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	1.7e-05	0.000283	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	1.7e-05	0.000283	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	1.7e-05	0.000283	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.66e-05	0.000277	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	1.66e-05	0.000276	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.66e-05	0.000276	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	1.65e-05	0.000275	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.61e-05	0.000268	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	1.6e-05	0.000267	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.59e-05	0.000265	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	1.58e-05	0.000264	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.56e-05	0.00026	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	1.56e-05	0.00026	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	1.54e-05	0.000256	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.51e-05	0.000251	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	1.5e-05	0.00025	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.48e-05	0.000246	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.47e-05	0.000246	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.47e-05	0.000245	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.47e-05	0.000245	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.46e-05	0.000244	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.46e-05	0.000243	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.44e-05	0.00024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.44e-05	0.00024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.43e-05	0.000239	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.43e-05	0.000239	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.4e-05	0.000233	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	1.4e-05	0.000233	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	1.39e-05	0.000232	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.39e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.39e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.39e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.39e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.39e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	1.38e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	1.38e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	1.38e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	1.38e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	1.38e-05	0.000231	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PLCB1—epilepsy syndrome	1.38e-05	0.000229	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—TH—epilepsy syndrome	1.37e-05	0.000228	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.37e-05	0.000228	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	1.36e-05	0.000227	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.34e-05	0.000223	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	1.34e-05	0.000223	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.29e-05	0.000216	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.29e-05	0.000215	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.29e-05	0.000215	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.29e-05	0.000215	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	1.29e-05	0.000214	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	1.29e-05	0.000214	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.27e-05	0.000212	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	1.27e-05	0.000211	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.25e-05	0.000209	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.25e-05	0.000209	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SST—epilepsy syndrome	1.25e-05	0.000209	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SST—epilepsy syndrome	1.25e-05	0.000208	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	1.25e-05	0.000208	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	1.25e-05	0.000208	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.24e-05	0.000207	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	1.24e-05	0.000207	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.23e-05	0.000205	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	1.22e-05	0.000204	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.22e-05	0.000204	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	1.22e-05	0.000203	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.18e-05	0.000197	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.18e-05	0.000197	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.18e-05	0.000196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	1.18e-05	0.000196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	1.18e-05	0.000196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.17e-05	0.000196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	1.17e-05	0.000196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	1.17e-05	0.000195	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.17e-05	0.000195	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	1.17e-05	0.000194	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.16e-05	0.000193	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.16e-05	0.000193	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	1.15e-05	0.000192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	1.15e-05	0.000192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.15e-05	0.000192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	1.15e-05	0.000192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HMOX1—epilepsy syndrome	1.14e-05	0.000191	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.13e-05	0.000188	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CAT—epilepsy syndrome	1.13e-05	0.000188	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	1.13e-05	0.000188	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ABCB1—epilepsy syndrome	1.1e-05	0.000183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.1e-05	0.000183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	1.09e-05	0.000182	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.08e-05	0.000179	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	1.07e-05	0.000179	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.07e-05	0.000178	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	1.07e-05	0.000178	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.05e-05	0.000175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	1.05e-05	0.000175	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.05e-05	0.000174	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	1.04e-05	0.000174	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GPX1—epilepsy syndrome	1.02e-05	0.00017	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	9.94e-06	0.000166	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	9.91e-06	0.000165	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	9.85e-06	0.000164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	9.82e-06	0.000164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	9.81e-06	0.000164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	9.79e-06	0.000163	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	9.51e-06	0.000158	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	9.48e-06	0.000158	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	8.99e-06	0.00015	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	8.96e-06	0.000149	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AGT—epilepsy syndrome	8.95e-06	0.000149	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOE—epilepsy syndrome	8.77e-06	0.000146	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	8.74e-06	0.000146	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	8.72e-06	0.000145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	8.71e-06	0.000145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	8.7e-06	0.000145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	8.68e-06	0.000145	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	8.67e-06	0.000144	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.41e-06	0.00014	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	8.38e-06	0.00014	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	8.31e-06	0.000139	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	8.29e-06	0.000138	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	8.09e-06	0.000135	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	8.06e-06	0.000134	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	7.91e-06	0.000132	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	7.89e-06	0.000131	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—POMC—epilepsy syndrome	7.53e-06	0.000126	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	7.52e-06	0.000125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	7.51e-06	0.000125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	7.49e-06	0.000125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	7.48e-06	0.000125	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	7.36e-06	0.000123	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	7.33e-06	0.000122	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	7.21e-06	0.00012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	7.18e-06	0.00012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	6.94e-06	0.000116	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	6.91e-06	0.000115	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	6.91e-06	0.000115	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	6.89e-06	0.000115	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ALB—epilepsy syndrome	6.87e-06	0.000114	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	6.32e-06	0.000105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	6.3e-06	0.000105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	6.18e-06	0.000103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	6.16e-06	0.000103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PTGS2—epilepsy syndrome	6.01e-06	0.0001	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	5.59e-06	9.31e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	5.57e-06	9.28e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	5.19e-06	8.65e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	5.17e-06	8.62e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	5.09e-06	8.48e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	5.07e-06	8.45e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.72e-06	7.87e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.71e-06	7.85e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	4.68e-06	7.8e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	4.66e-06	7.77e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	4.54e-06	7.57e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	4.53e-06	7.55e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	4.42e-06	7.37e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	4.41e-06	7.35e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.29e-06	7.15e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	4.27e-06	7.12e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	4.08e-06	6.79e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	4.06e-06	6.77e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.97e-06	6.62e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	3.96e-06	6.6e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—AKT1—epilepsy syndrome	3.02e-06	5.03e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.53e-06	4.22e-05	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	2.53e-06	4.21e-05	CbGpPWpGaD
